muscle weakness
Medications
Instructed in new medication Calcium and in S/E such as headache, weakness, dizziness, paresthesia, chest pressure, facial flushing, edema of feet, eye pain, nasal congestion, transient nausea, unusual taste, diarrhea, anorexia, vomiting, epigastric discomfort, abdominal pain, increased urinary frequency, nocturia, shortness of breath, rash, pruritus of ear lobes, inflammation at injection site, hypersensitivity reactions (anaphylaxis), chills and tender palms and soles.
Instructed in new medication Temazepam to manage insomnia. In addition, warned of possible S/E such as drowsiness, dizziness, lethargy, disturbed coordination, daytime sedation, confusion, nightmares, vertigo, euphoria, weakness, headache, fatigue, nervousness, anxiety, depression, blurred vision, diarrhea, nausea, dry mouth, physical and psychological dependence. Avoid alcohol during therapy. Caution when performing activities that require mental alertness or physical coordination. Instructed not to discontinue drug abruptly if it is taken for 1 month or longer.
Instructed in new medication Amitriptyline to manage depression. In additon, warned of possible S/E such as coma, seizures, hallucinations, delusions, disorientation, ataxia, tremor, peripheral neuropathy, anxiety, insomnia, restlessness, drowsiness, dizziness, weakness, fatigue, headache, extrapyramidal reactions, MI, stroke, arrhythmias, heart block, orthostatic hypotension, tachycardia, ECG changes, hypertension, edema, blurred vision, tinnitus, mydriasis, increased intraocular pressure, dry mouth, nausea, vomiting, anorexia, epigastric distress, diarrhea, constipation, paralytic ileum, urine retention, agranulocytosis, thrombocytopenia, leukopenia, eosinophilia, hypoglycemia, hyperglycemia, rash, urticaria, photosensitivity, diaphoresis and hypersensitivity reaction. Instructed to take full dose at bedtime but warned patient of possible morning orthostatic hypotension. Avoid alcohol during drug therapy. Consult MD before taking other medications. Avoid activities that require alertness and good psychomotor coordination until CNS effects of drug are known. Drowsiness and dizziness usually subside after a few weeks. Dry mouth may be relieved with sugarless hard candy or gum. Saliva substitutes may be needed. Instructed to use a sun block, wear protective clothing and avoid prolonged exposure to strong sunlight. To prevent photosensitivity reactions. Do not stop drug therapy abruptly.
Instructed in Vitamin B1 and in S/E such as weakness, restlessness, nauseas, uriticaria, pruritus, tenderness, and ?induration after IM administration.
.
Instructed in possible adverse reactions to Lasix, including dehydration, orthostatic hypotension, loss of potassium and other electrolytes, weakness, and fatigue.
Instructed in possible adverse reactions to Persantine, including diarrhea headache, weakness, flushing, dizziness, drop in B/P, nausea, vomiting, and skin rash. Instructed to take with meals if GI distress occurs and to watch for signs of bleeding.
Instructed in possible adverse reactions to Procardia, including dizziness, flushing, light headedness, headache, nausea, weakness, heartburn, and diarrhea.
Citalopram is an antidepresed and it produce side effects such as nausea, vomiting, diarrhea, loss of appetite, feeling unsteady, loss of coordination; or headache, trouble concentrating, memory problems, weakness, confusion, hallucinations, fainting, seizure, shallow breathing or breathing that stops and drowsiness.
Patient was educated about Digoxin 0.125 mg 1 tablet oral daily, side effects may include: fatigue headache, weakness, blurred vision, yellow vision, ARRHYTHMIAS , bradycardia, anorexia , nausea , vomiting , diarrhea, this medication has an action time of 30-120 min, the peak time is about 206 hr and the duration is about 2-4 days.
Patient was educated about potassium 10 meq 1 tablet oral daily and the importance to report dark, tarry, or bloody stools; weakness; unusual fatigue; or tingling of extremities. Notify if nausea, vomiting, diarrhea, or stomach discomfort persists. Dosage may require adjustment. Emphasize the importance of regular follow-up exams to monitor serum levels and progress.